Ischemic strokes are often accompanied by serious brain injury and poor prognosis, but the molecular mechanisms of primary and secondary injury have not been fully understood. The aim of the present study was to investigate the protein profile in the rat pituitary, adrenal gland, and splenic lymphocyte using proteomics techniques, and to elucidate potential changes in the immune neuroendocrine system following cerebral ischemia injury in rats. Out of the 41 differentially expressed protein spots identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-MS-TOF), 13 proteins were closely related to the immune and/or the neuroendocrine system, and the other proteins might have different functions through other mechanisms in middle cerebral artery occlusion (MCAO) rats. The results showed that (i) the immune neuroendocrine system was obviously changed, and the changes might be important pathological mechanisms in brain injury after cerebral ischemia, and (ii) ischemic brain damage is co-regulated by several mechanisms. The results might lay the foundations for further research on pathological mechanisms in cerebral ischemia.
Ischemic stroke is an acute cerebrovascular disease that remains a leading cause of adult mortality and longterm disability, with very few options for effective treatment. Cerebral ischemia triggers a complex series of biochemical and molecular mechanisms that impairs neurologic functions through a breakdown of cellular integrity mediated by excitotoxic glutamatergic signaling, ionic imbalance, free-radical reactions, intracellular calcium, eicosanoids, etc. In addition to the above mechanisms, inflammatory immune reactions and multiple neuroendocrine abnormalities are currently thought to contribute to neuronal death following cerebral ischemia. 1, 2) The concept of a neuroendocrine-immune network was first described by Besedovsky in 1977.
3) There is accumulating evidence that the neuroendocrine and immune systems communicate bidirectionally. 4, 5) The neuroendocrine system regulates the function of the immune system by neurotransmitters, hormone secretion, cytokines secreted by neurocytes, and peripheral nerve synapses. The recent literature suggests that the hormones produced by the hypothalamic-pituitaryadrenal (HPA) axis are major part of the neuroendocrine system and have important functions in health and disease by regulating immune responsiveness. 6) Conversely, immunological system feedback acts on the neuroendocrine system by a variety of cytokines and hormone-like substances produced by immunocompetent cells.
It has been found that acute cerebral arterial thrombosis can cause severe stress reactions due to ischemia and oxygen deficiency in brain tissue. 7) In this process, cytokines produced by immune-mediated inflammatory reactions such as interleukin (IL)-1, tumor necrosis factor (TNF)-, and IL-6 are able to stimulate the central neural system to activate the HPA axis, which induces the pituitary to release more adrencocorticotropic hormone (ACTH). 5) ACTH reaches the adrenal gland with the circulation and induces the expression and secretion of glucocorticoids which suppress the production of cytokines and other pro-inflammatory mediators, including IL-1, IL-11, IL-12, interferon-, TNF-, chemokines (IL-8), and prostaglandins. 8) Glucocorticoids also facilitate the release of anti-inflammatory mediators, such as IL-4, IL-10, and transforming growth factor-, and have strong antiproliferative properties and apoptotic effects in immune cells. 9) In the end, cytokines can activate the release of glucocorticoids, which in turn suppress further cytokine synthesis in a classic negative feedback loop. 4, 10) From these results, it appears that bilateral communication between the immune and neuroendocrine systems plays an essential role in cerebral ischemia. The peripheral immune response as y To whom correspondence should be addressed. Fax: +86-731-4327568; E-mail: l.qinghua@yahoo.com Abbreviations: ACTH, adrencocorticotropic hormone; ALDH, mitochondrial aldehyde dehydrogenase; APO, apolipoprotein; ANNX, annexin; COX, cytochrome c oxidase; CKB, creatine kinase B; CPT, carnitine palmitoyltransferase; CTSB, cathepsin B; DRP-2, dihydropyrimidinase-related protein2; FGG, fibrinogen, gammapolypeptide; GRP58, protein disulfide-isomerase A3; G6PD, glucose-6-phosphate 1-dehydrogenase; GMFG, glia maturation factor gamma; GDI, GDP dissociation inhibitor; GS, glutamine synthetase; HPA, hypothalamic-pituitary-adrenal; HSP70, heat shock protein 70; IVD, isovaleryl-CoA dehydrogenase; ILs, interleukins; LAP3, leucine aminopeptidase 3; MALDI-TOF-MS, matrix-assisted laser desorption/ionization time of flight mass spectrometry; MCAO, middle cerebral artery occlusion; NDKB, nucleoside diphosphate kinase B; PEBP-1, phosphatidylethanolamine-binding protein1; PGAM, phosphoglycerate mutase; PRDX, peroxiredoxin; PLA2, phospholipase A2; Rp, ribosomal protein; 2-DE, two-dimensional polyacrylamide gel electrophpresis; PRSS, serine protease; STAR, steroidogenic acute regulatory protein; TNF, tumor necrosis factor; UPS, the ubiquitin proteasome system; UCH-L1, ubiquitin carboxyl-terminal hydrolase isozyme L1 mediated by the spleen is a major contributor to inflammation after ischemic stroke, 11) and stroke can induce an extensive apoptotic loss of lymphocytes, and results in rapid and widespread production of proinflammatory factors by splenocytes. 12) In the present report, we chose the pituitary, the adrenal gland, and splenic lymphocytes to carry out our research.
In the past several years, a number of proteomics studies have profiled protein expression alterations in the blood plasma, serum, cerebral cortex, and cerebrospinal fluid. [13] [14] [15] Identification of these proteins with altered expression levels following ischemic stroke might provide information on specific proteins associated with cerebral arterial thrombosis, as well as potential clinical targets for neuro-protective therapy. However, little is known about the effects of stroke on protein expression in the neuroendocrine-immune system following cerebral arterial embolism. The purpose of the present study was to investigate protein profiles in the rat pituitary, adrenal gland, and splenic lymphocyte and to elucidate potential changes in the immune neuroendocrine system following experimental stroke induced by unilateral occlusion of the middle cerebral artery (MCAO).
Materials and Methods
Animal. Thirty male Sprague-Dawley rats (180-200 g body wt) were provided by Central Animal Care of Central South University, Changsha, China, and were maintained under a 12:12-h light-dark cycle with food and water ad libitum. All the animals received humane care in compliance with the university's guidelines. They were randomly divided into two groups, as follows: a focal cerebral ischemia group and a sham operation group. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Central South University. Focal cerebral ischemia was induced by MCAO, as previously described.
16) The rats receiving a sham operation were subjected to the same surgical procedures, but without occlusion of the middle cerebral artery. Twenty-four h after MCAO, the rats were sacrificed, and three rats were selected randomly, from which the cerebrum was sectioned into eight 2-mm thick coronal slices using a brain-sectioning block. The infarct region was visualized by staining with a 0.1% 3,5-triphenyltetrazolium chloride (TTC) solution for 30 min under dark conditions. 17) The infarct area was analyzed with a scion image system (Beta 4.0.2 Version), and the true infarct volume was calculated as follows: true infarct volume (TI) per section = I Â Tc/Ti (where infarct volume I = infarct area Â 2 cm 3 , Tc = area of contralateral hemisphere Â 2 cm 3 , Ti = area of ipsilateral hemisphere Â 2 cm 3 . Percentage hemispheric true infarct volume = (
IPG-2-DE and image analysis. Tissues of the pituitary and the adrenal gland, as well as spleen lympholeukocytes were obtained from rats receiving 24-h MCAO or the sham operation. The obtained tissues and the isolated lympholeukocytes were frozen with liquid nitrogen immediately and stored at À70 C until analysis. The tissues and cells were disrupted in a homogenization buffer containing 30 mM Tris, 7 M urea, 2 M thiourea, 4% CHAPS, and 20 mM DTT, and then the lysates were centrifuged at 12,000 rpm for 60 min at 4 C. The supernatant was precipitated by the TCA sediment method to recover total protein, and the interfering components were removed using a 2-D Clean-Up Kit (GE Healthcare, Piscataway, NJ).
A total of 400 mg of total protein was loaded onto a 240 mm linear IPG strip (pH 3-10, Amersham Biosciences, Piscataway, NJ) for firstdimensional isoelectric focusing (IEF). Protein separation by second dimension SDS-PAGE (Bio-Rad, Hercules, CA) was carried out following the instructions of the manufacturer. After electrophoresis, the gels were stained with Coomassie Blue and scanned with an image scanner (Amersham Biosciences). Software of Labscan Software (Applied Biosystems, Foster City, CA) was employed in image analysis, including background abstraction, spot intensity calibration, spot detection, and matching. The intensity of each spot was quantified by a calculation of spot volume after normalization of the gel image. Each sample was produced in triplicate, and the paired Student's t test was used to evaluate the average protein abundance change corresponding to each target spot across the gels. Protein spots with more than 2-fold significant changes in density (paired t-test, p 0:05) in a consistently increased or decreased direction were considered to be differentially expressed, and were selected for further identification.
18)
MALDI-TOF-MS and database analysis. Protein spots (n ¼ 55) with differential expression levels between the groups MCAO and sham-operated were manually excised from the 2-DE gels, washed, destained, dried, and then incubated in digestion solution (40 mM NH 4 HCO 3 in 9% acetonitrile solution, and 40 mg/ml proteomics grade trypsin) for 12 h at 37 C. The tryptic peptide mixture was analyzed by MALDI-TOF-MS on a voyager time-of-flight mass spectrometer (Applied Biosystems). The MALDI-TOF mass spectra were used to identify proteins by peptide mass fingerprinting in the MASCOT search engine (http://www.matrixscience.com/) using the following parameters: Rattus for taxonomy, AE0:5 Dalton for mass tolerance, carbamidomethyl (cysteine) for fixed modification, and oxidation (methylation) or none for variable modification. The missed cleavage sites allowed were up to 1, and a MOWSE score of > 58 indicated that the protein matches were significant.
Western blot. Total protein (50 mg) was separated on 12% sodium dodecyl sulfate-polyacrylamide (SDS-polyacrylamide) gels under reducing conditions. Following blocking with 5% skim milk, the transferred membranes were incubated overnight at 4 C with antibodies against rat HSP70 (Santa Cruz Biotechnology, Santa Cruz, CA), PRDX3 (Santa Cruz Biotechnology, Santa Cruz, CA), STAR (Santa Cruz Biotechnology, Santa Cruz, CA), and UCH-L1 (Santa Cruz Biotechnology, Santa Cruz, CA) at 1:200 dilution. They were subsequently incubated with HRP-conjugated second antibodies (Amersham Biosciences) at 1:5,000 dilution. Bands were visualized by the enhanced chemiluminescence (ECL) method. All western blot analysis for each interested protein was performed in triplicate. 19) Statistical analysis. Relevant data were gathered by two-tail independent sample t-test using SPSS for Windows, except for proteomic analysis. Values were expressed as mean AE S.E.M. The critical P level set for significance was 0.05.
Results

Brain tissue injury caused by focal cerebral ischemia
Under staining with 0.1% TTC, the infarcted tissues caused by MCAO were white in color on the injured side, while the normal brain tissues on the non-injured side and the sham-operated controls were pink in color (Fig. 1) . The total infarcted volume of the brain 24 h after MCAO was 15-45% (n ¼ 3).
Proteome differential expression between the MCAO and the sham-operated group
Representative 2-DE maps of the MCAO and sham groups are provided in Fig. 2 for the pituitary, Fig. 3 for the adrenal gland, and Fig. 4 for spleen lympholeukocytes. As compared with the control 2-DE maps, the gels of the pituitary displayed approximately 1,100 protein spots, with 15 differentially expressed spots, the 2-DE maps of the adrenal gland displayed 800 spots, with 26 differentially expressed protein spots, and the 2-DE gels of the spleen lympholeukocytes displayed 1,200 spots, with 15 differentially expressed spots. All of these 56 protein spots with different expression levels were further analyzed by MALDI-TOF-MS in combination with a database search, and 41 spots were finally identified by good peptide coverage and significant scores (Figs. 2-4 and Table 1 ). Among these 41 identified spots, 11 proteins were found in the pituitary, 20 spots were identified in the adrenal gland, and 10 spots were identified in the spleen lympholeukocytes. Overall, the sequence of coverage rate of differentially expressed proteins was 25-75%, and the proteins were divided into the following eight groups based on their functions using information obtained from the SwissProt and NCBInr websites: antioxidant, metabolic enzymes, protein biosynthesis and degradation, signal Infracted tissues stained white with 2,3,5-triphenyltetrazolium chloride (TTC) while normal tissue remained pink. Sham-controls (not shown) were similar to the non-lesioned contralateral hemisphere. The percentage of hemispheric true infarct volume was typically 15-45%. Proteins (400 mg) were focused on 24 cm IPG strips (pH 3-10), and separated in SDS polyacrylamide gradient gels. Following Coomassie Blue staining, the gels were subjected to PDQuest imaging analysis. Fifteen protein spots significantly changed in pituitary between the sham-controls and MCAO groups are marked with arrows. Proteins (400 mg) were focused on 24 cm IPG strips (pH 3-10), and separated in SDS polyacrylamide gradient gels. Following Coomassie Blue staining, the gels were subjected to PDQuest imaging analysis. Twenty-six protein spots significantly changed in adrenal gland between the sham-controls and MCAO groups are marked with arrows. transduction, structural proteins, chaperone, thromboxane enzyme, and others (Fig. 5) .
Validation of differentially expressed proteins
To confirm the differential expression levels of the proteins by the comparative proteomics approach, the expressional levels of the partial proteins in shamoperated and MACO were measured by western blot analysis. Figure 6A shows representative western blot analysis results for HSP70, PRDX3, STAR, and UCH-L1 expression in the adrenal glands of the two groups. Figure 6B shows the relative volume intensity of each protein. The results were identical to the results obtained by 2-DE. Figure 6C shows magnified pictures of HSP70, PRDX3, STAR, and UCH-L1 in the 2-DE gels.
Discussion
This is, as far as we know, the first report of pituitary, adrenal gland, and splenic lymphocyte protein analysis, and the first report of an investigation to delineate potential changes in the immune neuroendocrine system following cerebral ischemia injury by proteomics. Out of the 41 differentially expressed protein spots identified, 13 proteins, including steroidogenic acute regulatory protein (STAR), were closely related to the immune and/or the neuroendocrine system in the MCAO rats. The 13 proteins might be mediators between the immune system and the endocrine system after ischemic stroke. The other proteins might play different functions through other mechanisms in ischemic brain damage. The identified proteins are discussed individually below.
Ischemic stroke can activate the HPA axis to release steroid hormone, and one of important regulation factor is STAR during the process of synthesizing steroid hormones. Our results for up-regulation of STAR in MCAO suggest that activation of the HPA axis induces the expression of STAR. A recent study indicates that proinflammatory cytokines TNF-and interferon-are able to regulate the expression of STAR. 20) Steroid hormones, which act as neuroendocrine regulators, have a major impact on brain injury by regulating the inflammatory response after ischemic stroke. 21) Evidence suggests that chronic estrogen treatment suppresses leukocyte adhesion and the induction of vascular inflammatory mediators in ischemic brain injury. On the other hand, testosterone and progesterone treatment have been found to enhance the induction of inflammatory mediators by endotoxin. 22, 23) In addition, stroke patients with increased cortisol might have a strong inflammatory response, with increased IL-6 levels, white blood cell counts, and fibrinogen. 24) Fibrinogen is involved in inflammatory reactions, in which it regulates leukocyte-endothelial cell interactions and mediates the release of proinflammatory cytokines and chemokines. It can induce activation of macrophage cells. 25) It has been found to be an independent stroke risk factor, and it remains persistently elevated after stroke. Furthermore, fibrin-mediated inflammatory processes drive secondary tissue damage in the brain.
26) The serine protease thrombin cleaves peptides of the fibrinogen and chains. The released fibrinopeptide can independently modulate inflammatory responses by acting as a chemoattractant for leukocytes. 27) Apolipoprotein E (APOE), an important mediator of cholesterol and lipid transport in the brain, has an important role in development and regeneration in the nervous system. 28, 29) Our results suggest that up-regulated APOE might function in the regeneration of nerves injured by cerebral ischemia. Recent studies show that sex hormone can regulate APOE. 30) In this study, we found that STAR, fibrinogen, serine protease and APOE are up-regulated after ischemic stroke. We conclude that (i) APOE expression might be regulated by STAR via modulating steroid hormone and might play an important role in ischemic stroke; (ii) serine proteases depolymerize fibrinogen, so that fibrinogen mediates inflammatory reactions; and (iii) STAR might modulate the inflammatory response directly or indirectly by increasing fibrinogen expression. In turn, inflammatory cytokines can regulate STAR expression, and thus form a circuit between the endocrine and the immune system. Studies indicate that oxidative stress is an important mechanism of neuronal injury to ischemic brain tissue. 31) Adaptation to stress results in a variety of Proteins (400 mg) were focused on 24 cm IPG strips (pH 3-10), and separated in SDS polyacrylamide gradient gels. Following Coomassie Blue staining, the gels were subjected to PDQuest imaging analysis. Fifteen protein spots significantly changed in spleen lympholeukocytes between the sham-controls and MCAO groups are marked with arrows. neuroendocrine responses that activate the HPA axis and induce peroxiredoxin (PRDX) (an antioxidant enzyme) and glutamine synthetase (GS) (a key enzyme that glutamate converts to glutamine) expression. 4, 32, 33) Our results for up-regulated PRDX and GS suggest that oxidative stress was enhanced after cerebral ischemia. PRDXs are involved in the cell oxidation-reduction reaction, antioxidant defense, cell proliferation, and apoptosis. 34, 35) In recent years, increasing interest is focused on the relationship between PRDX and inflammation. Studies indicate that PRDX activates macrophages to secrete anti-inflammatory mediators such as IL-4, IL-5, and IL-13, and is an important regulator of TNF-signaling pathways. 36, 37) In the introduction, we stated that inflammatory cytokines can regulate the HPA axis. Thus, PRDX might modulate the HPA axis indirectly. In the present study, our finding of PRDX2 up-regulation in the pituitary and splenic lymphocytes and PRDX3 up-regulation in the adrenal gland in MCAO rats suggests that PRDXs play an active role in the neuroprotective mechanism against anti-oxidative damage and are involved in regulating the immune inflammatory response. We can surmise from the above that PRDX is the mediator between the immune system and endocrine system after ischemia stroke. GS is a critical factor in the neurotoxicity produced after stroke. 38) In a number of cell types, glucocorticoid hormones induce inflammatory cytokines, such as IL-1 and TNF-, that suppress the expression of GS. 39, 40) In this study, the lower expression of GS in MCAO rats was the result of regulation by glucocorticoid hormones induced by the HPA axis. The protein is perhaps closely related to the immune and endocrine systems in ischemic brain damage. Proteins found to be differentially labeled by 2-DE analysis were excised from the gels, digested with trypsin, and analyzed by MALDI-TOF-MS in combination with a database search. Among these 41 identified spots, eight increased and three decreased protein expression were found in the pituitary from spot 1 to spot 15 in the table. From spot 16 to spot 41, twenty spots were identified in the adrenal gland and fourteen were up-regulated, and six were down-regulated. Ten spots were identified in spleen lympholeukocytes and nine spots were up-regulated, one spots were down-regulated, from spot 42 to 56 in the table. The Swiss-Prot accession number, the % coverage of analyzed peptides, the Mass and pI from the database, and an average 2-fold difference between pairs (paired t-test, p < 0:05) are shown for each protein.
The ubiquitin proteasome system (UPS) is a major cellular protein degradation pathway involved in the modulation of proteins controlling inflammation, cellcycle regulation, and gene expression. 41) Experimental results show that ischemic and hypoxic trauma and oxidative stress following stroke evoke a change in UPS. 42) There are now overwhelming data suggesting that the UPS has an important function in the immune and inflammatory responses. It is involved in antigen processing and presentation to cytotoxic T cells and the activation in nuclear factor-kappa B, the central transcription factor in the immune system, and contributes to cerebral ischemic injury. 41) Hence, some researchers put it forward that UPS inhibitors suppress the activation of nuclear factor-kappa B by reducing the levels of multiple proinflammatory proteins, providing anti-inflammatory effects and attenuating the inflammatory cascade in cerebral ischemia, leading to a reduction in ischemic damage. 41) Ubiquitin C-terminal hydrolase L1 (UCH-L1) is an important component of the UPS. 43) In this study, obvious down-regulation of UCH-L1 was apparent in MCAO rats, which indicates that the protein might control the UPS by reducing expression, thereby alleviate ischemic brain damage. It also indicates that it is closely related to the immune inflammatory response.
Chaperones were further major proteins in this study, including members of the heat shock protein family, such as HSC70, HSP70, and protein disulfide-isomerase (GRP58). It is recognized that the expression of HSP70 enhances under manifold stress and is involved in protecting the brain from insults due to stroke. The mechanism has been generally considered to lie in its The proteins were divided into eight groups based on their functions using information obtained from the Swiss-Prot and NCBInr websites: antioxidant, metabolic enzymes, protein biosynthesis and degradation, signal transductions, structural proteins, chaperone, thromboxane enzyme, and so on. molecular chaperone, but recent study shows that HSP70 also modulates inflammatory responses by inhibiting activation of an inflammatory transcription factor, nuclear factor-kappa B. 44) In addition, HSP70 might directly interfere with cell death pathways such as those involved in apoptosis and necrosis. 45) HSP70 inhibits cytochrome C release and inhibit apoptosis-inducing factor translocation to the nucleus thereby reducing ischemic brain injury. 46) In this study, HSP70 was upregulated in MACO, which further indicates the role of HSP70 in neuroprotection from brain injury following stroke and it relevance to the inflammation reaction. The down-regulation of cytochrome C might a modulation result of HSP70.
Glia maturation factor (GMF) is a highly conserved protein mainly localized in the mammalian central nervous system. Recent studies on GMF show that it has an important role in immunomodulatory and proinflammatory functions in the CNS by enhancing the production of Th1-type inflammatory cytokines, such as TNF-, IL-6, and IFN-, 47) but no study of the relationship between GMF and the inflammatory response after ischemic stroke has been reported. In this study, an obvious up-regulation of GMF was observed in MCAO, which indicats it might be a novel protein that modulates the inflammatory reaction after ischemic brain injury.
The annexins are a calcium-binding protein family. Their function is not well understood. Annexion 3 is a blocking agent of phospholipase A2 (PLA2). PLA2 is a ubiquitous enzyme that specifically catalyzes hydrolysis of membrane phospholipids to produce lysophospholipids and free fatty acid, which provide a substrate for eicosanoid biosynthesis. Hence, it is involved in the inflammation reaction by targeting cells directly or indirectly. 48) After stroke, the expression of inflammatory cytokines (TNF-, IL-/, and IL-6) is increased, and can this induce phospholipase A2 synthesizing enzymes. 49) Our finding of down-regulation of annexion 3 in MCAO suggests that the protein fail to inhibit the inflammatory reaction caused by PLA2 following ischemic stroke, thereby aggravate brain injury.
Some proteins with altered expression are involved in glucolysis and the tricarboxylic acid cycle, including nucleoside diphosphate kinase B, phosphoglycerate mutase 1, isovaleryl-CoA dehydrogenase, mitochondrial aldehyde dehydrogenase, glucose-6-phosphate 1-dehydrogenase, and NADH dehydrogenase. These changes indicate that disturbance of energy metabolism occurs following acute brain ischemia injury.
The other differential expression proteins are less reported about the correlations between the proteins and immune neuroendocrine system than the proteins mentioned above, including metabolism, protein biosynthesis relation protein, signal transduction, and structural proteins which call for further study.
In conclusion, the present study perhaps gives new insight into the regulation of the neuroendocrine and immune systems following cerebral ischemia. Many protein expressions are changed in the endocrine system and the immune system, and they might represent important pathological mechanisms after ischemic stroke. The roles of these identified proteins are not independent, but have inextricably linkages with other proteins, furthermore, and many proteins play important roles after ischemic stroke, not only in the immune neuroendocrine system, but also through other mechanisms. It is conceivable that ischemic brain damage is co-regulated by various mechanisms in a variety of ways. Further studies will investigate the interaction network of protein-to-protein in the immune neuroendocrine system. When the network of protein functions has been described correctly, this will be breakthrough in the study of pathological mechanisms after stroke, and will carry important implications for clinical treatment.
